Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial

OBJECTIVE: To compare patient reported measures of function, health related quality of life (QoL), and satisfaction with medication among patients with rheumatoid arthritis (RA) treated with methotrexate (MTX), etanercept, or both for up to 1 year. METHODS: In a 52 week, double blind, clinical trial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van der Heijde, D, Klareskog, L, Singh, A, Tornero, J, Melo‐Gomes, J, Codreanu, C, Pedersen, R, Freundlich, B, Fatenejad, S
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2006
Assuntos:
Extended Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798055/
https://ncbi.nlm.nih.gov/pubmed/16079172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.035709
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados